Amedisys Appears in 14.9% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Answer Capsule

In November 2026, Amedisys appeared in 40 of 269 AI answers included in the Home Health Care benchmark (14.87%). It received 23 recommendations (8.55%), with 15 Top 3 placements and 7 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

• How do Amedisys mentions, recommendations and placements compare with its Home Health Care peers?

Amedisys recorded 40 mentions (14.87%) and 23 recommendations (8.55%) across 269 answers included in the benchmark. Top 3 placements numbered 15; first-place recommendations numbered 7. Framing among its mentions was 23 positive, 17 neutral and 0 negative.

Amedisys appears in a modest share of benchmark answers and is recommended in fewer still, placing it in the lower half of the tracked set. The gap between mentions and recommendations matters more than the raw position: the company is discussed without being endorsed. That is the space where better-sourced, better-framed content can help.

Framing is not the problem. Almost all mentions carry positive or neutral wording, with none negative. The shortfall sits in affirmative endorsement, not tone. Proposed work should therefore focus on giving answer engines clear, verifiable reasons to recommend Amedisys, rather than polishing language that already reads well.

What changed since last month

Questions This Section Answers

• How did Amedisys counts and coverage differ across the available monthly snapshots?

From October 2026 to November 2026, Amedisys' mention count rose from 36 to 40, while its recommendation count rose from 13 to 23. The recommendation rate was 4.05% and 8.55% respectively.

The monthly record moves around without settling into a trend. Mentions and recommendations both rose from the prior month, and the top-three and first-place counts rose alongside them. That is a better month on the recorded measures, but the samples differ between months, so the movement should be read as observation rather than proof of progress.

Comparability is the key limit. Each month draws a different set of answers, and a change in totals does not tell us why counts or rates moved. The agency should treat this month as a fresh baseline point and avoid presenting the rise as evidence that any prior action worked.

Step 1. Measure

Questions This Section Answers

• What should the agency measure and verify first for Amedisys?

AI answers contained 11 conflicting claims about Amedisys: 0 critical, 3 high, 8 medium, 0 low. Of these, 3 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

The fact-check list is the practical starting point. Several conflicting claims about Amedisys were recorded, and a small group carries high priority. Those ratings order the verification work; they do not mean a company or publisher got something wrong. The first job is to establish what is actually true today.

A visibility comparison alongside that list would let the client see where Amedisys sits relative to peers while the claims are checked. Proposed work: a baseline scorecard and a scoped fact-review register, each entry with an owner, an evidence requirement and a review status, so priorities are set on verified ground rather than on AI assertions.

Step 2. Make the website consistent

Questions This Section Answers

• Which recorded claim differences about Amedisys should be verified before proposed page edits?

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed topics cluster around ownership and size ranking. In each case the recorded answers disagree with one another, and both sides are quoted AI output rather than confirmed fact. Different dates or different source pages can produce an apparent conflict, so the entity, the date and the source need resolving before anyone decides a correction is warranted.

Proposed work is verification first, page briefs second. The agency would confirm the current position from primary sources, then draft conditional briefs for the relevant company pages only where the verified facts support a change. Ambiguous matches stay out of the correction queue until the entity is clear.

Step 3. Align the external narrative

Questions This Section Answers

• Which cited third-party pages are relevant to fact review for Amedisys?

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review are the natural targets for source checking, but selection is not accusation. A page linked to a conflicting claim is not necessarily its cause, and the same answer can draw on more than one page. Current contents must be read before any request is made.

Proposed work: review each shortlisted source against verified facts, then decide separately whether a correction request, a clarification or no action is appropriate. Requests should be evidence-backed and courteous, and responses logged. Where a page is accurate, the right outcome is a documented no-change decision, not a push for edits.

Step 4. Optimize priority company pages

Questions This Section Answers

• Which observed Amedisys website pages should receive review briefs?

The company's website was cited 5 times across 5 distinct page addresses; the table shows 5 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The company site was cited across a handful of distinct pages, including the homepage, an about page, an investor services page and two location pages. Citation counts are small, and a cited page is not automatically one that accompanied a recommendation. The zeros in the answer columns simply mean no matching answers were recorded.

Proposed work: page briefs built on approved facts and the questions buyers actually ask, checked against what each page already covers. The location pages deserve attention because local queries appear in the observed set. Briefs should specify the audience question, the approved answer and the evidence behind it.

Step 5. Publish around buyer questions

Questions This Section Answers

• Which observed buyer questions support content briefs for Amedisys?

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The observed questions are dominated by size and best-agency framing, with a smaller local query and several general care-service phrasings. These are recorded answer observations, not search volume or proof of missing content. They show which questions answer engines are already fielding when Amedisys comes up.

Proposed work: check existing coverage first, then draft buyer-question briefs only where a genuine gap exists. Content should answer the question directly, cite approved facts and avoid restating rankings the company cannot substantiate. Local coverage should follow the same discipline.

Our 90-day action plan

Questions This Section Answers

• How should the agency sequence the proposed Amedisys work and judge completion?

The first month establishes the baseline scorecard, the scoped fact-review register and the page and source shortlist, each record with an owner and evidence requirement. The second month turns verified facts into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions, requests and responses recorded separately.

The third month adds buyer-content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, and comparability limits are stated alongside any month-to-month reading. Nothing in the plan promises a visibility gain; it promises disciplined, verifiable work the client can audit.

Methodology

Questions This Section Answers

• How are Amedisys answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 269 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5113 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The answers were collected under the benchmark's inclusion rules, and the exact collection dates have not been verified. A company counts as recommended only when an answer endorses it with positive wording; top-three and first-place counts sit inside those recommendations rather than adding to them. Answers can cover several companies, so company counts do not sum to distinct answers.

Monthly samples differ, so comparisons describe recorded movement, not its cause. Cited pages and disputed claims still need independent verification before any correction is considered.

Our first three priorities

First, resolve the ownership and size-ranking conflicts from primary sources. These claims shape how answer engines describe Amedisys, and until they are settled no correction or page change should proceed. The fact-review register gives that work a clear owner and evidence standard.

Second, review the shortlisted external pages against verified facts and decide, page by page, between a justified request and a documented no-change. Third, prepare buyer-question briefs for the size and best-agency questions, checking existing coverage before proposing anything new. Each step produces an auditable record, and none is presented as a guaranteed route to more recommendations.